How the product works:
Who it is recommended for:
Studies and clinical evidence:
Clinical studies have demonstrated that posaconazole significantly reduces the incidence of invasive fungal infections and mortality in high-risk patients. It is recommended by international guidelines such as ESCMID and IDSA as a first-line antifungal prophylactic and therapeutic agent.
The medicine works by inhibiting fungal cell membrane synthesis, leading to growth suppression and pathogen elimination.
The tablets are taken orally, preferably with food to enhance absorption. Dosage and duration of treatment are determined by a healthcare professional based on clinical indications and patient condition.
Contraindications
Side effects:
